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Abstract
Inhibition of angiogenesis might be a therapeutic ap-
proach to prevent joint destruction caused by the over-
growing synovial tissue during chronic joint inflamma-
tion. The aim of this study was to investigate angiogene-
sis in the knee joint of mice with antigen-induced arthritis
(AIA) by means of intravital microscopy. In 14 mice
(C57BL6/129Sv) intravital microscopic assessment was
performed on day 8 after AIA induction in two groups
(controls, AIA). Synovial tissue was investigated by in-
travital fluorescence microscopy using FITC-dextran
(150 kD). Quantitative assessment of vessel density was
performed according to the following categories: func-
tional capillary density (FCD, vessels !10 Ìm in diame-
ter), functional vessel density (FVD, vessels 110 Ìm) and
FVD of vessels with angiogenic criteria (convoluted ves-
sels, abrupt changes of diameter, vessels which are gen-
erated by sprouting and progressively pruned and re-
modelled). Microvessel count was performed using im-
munohistochemistry. There was no significant differ-
ence in FCD between the control group (337 B 9 cm/cm2;
mean B SEM) and the AIA group (359 B 13 cm/cm2). The
density of vessels larger than 10 Ìm diameter was sig-
nificantly increased in animals with AIA (135 B 10 vs. 61
B 5 cm/cm2 in control). The density of blood vessels with
angiogenic criteria was enhanced in arthritic animals (79
B 17 vs. 12 B 2 cm/cm2 in control). There was a signifi-
cant increase in the microvessel count in arthritic ani-
mals (297 B 25 vs. 133 B 16 mm–2 in control). These
findings demonstrate that angiogenesis in murine AIA
can be assessed quantitatively using intravital microsco-
py. Further studies will address antiangiogenic strate-
gies in AIA.
Copyright © 2003 S. Karger AG, Basel
Introduction
Rheumatoid arthritis (RA) is a chronic progressive dis-
ease involving both local and systemic inflammation that
causes joint destruction, deformity, disability and prema-
ture death [1]. In RA, the vascular endothelium is among
the key targets of circulating mediators of inflammation
and controls the trafficking of cells and molecules from
the bloodstream toward the synovial tissue. Local blood
vessel proliferation allows the pannus to develop and
grow, thereby promoting cartilage and adjacent bone
destruction and joint remodeling, leading to severe pain
and impairment of mobility [2, 3]. These changes are
accompanied by alterations in the synovial microcircula-
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tion [4]. RA synovitis involves local activation of lympho-
cytes, inflammation, and synovial hyperplasia as well as
angiogenesis [1].
Angiogenesis, the process by which new blood vessels
are formed by outgrowth from existing ones, plays an
important role in active proliferation of inflammatory
synovial tissue, which is a principal pathophysiological
feature in RA. The RA synovial tissue is rich in new ves-
sels. Enhanced angiogenic activity perpetuates leukocyte
extravasation and thus the progression of RA [5]. It has,
therefore, been suggested that the inhibition of blood sup-
ply, resulting in a suppression of pannus growth, could be
a beneficial element of antiarthritic therapy [6].
Because RA is an angiogenic disease [7], recent re-
search efforts have focused on the inhibition of angiogen-
esis. In a rat model of arthritis, the antiproliferative agent
TNP 470 was found to suppress established disease, in
parallel with marked inhibition of pannus formation and
neovascularization [8–10]. More recently specific antago-
nists of ·Vß3 were used in a rabbit model resembling
human RA. Intra-articular injections of ·Vß3 antibody
decreased vascularity in the arthritic synovium, which
was associated with a significant decrease of all arthritis
parameters including joint swelling and synovitis [11].
Most of the investigations regarding antiangiogenic
strategies and their effects on the rheumatoid synovial
microcirculation have relied on clinical and histological
parameters. It is still unclear whether the density of blood
vessels in the arthritic synovium per unit area is in-
creased, unchanged or even gets reduced [12, 13]. The
lack of a suitable animal model has restricted previous
efforts primarily to histological studies. In our recently
published study intravital microscopy has been success-
fully used to quantify the leukocyte-endothelial cell inter-
action in mouse antigen-induced arthritis (AIA) [14]. Yet,
no studies have been reported which directly demonstrate
the in vivo effects of antiangiogenic therapy on the syno-
vial microcirculation. Therefore, it was our aim to investi-
gate angiogenesis and to develop a quantitative technique
for assessing angiogenesis in the knee joint of mice with
AIA in vivo, with the use of our recently developed model
for intravital microscopic analysis of the mouse synovial
microvasculature [15].
Materials and Methods
Animals
Female inbred Balb/c mice (C57BL6/129Sv, Charles River, Sulz-
feld, Germany) at 8–10 weeks of age, weighing 18–21 g were used for
the experiments. The animals were kept in an air-conditioned envi-
ronment with 12-hour light/dark cycles, housed in single cages and
fed laboratory chow (Ssniff, Spezialdiäten, Soest, Germany) and
water ad libitum. Before starting the experiments, they were random-
ly assigned to the control or AIA group.
Antigen-Induced Arthritis 
On days –21 and –14 prior to the induction of arthritis mice were
immunized by a subcutaneous injection of 100 Ìg of methylated
bovine serum albumin (mBSA; Sigma, Deisenhofen, Germany), dis-
solved in 50 Ìl of Freund’s complete adjuvant (Sigma) and supple-
mented with 2 mg/ml heat-killed Myobacterium tuberculosis strain
H37RA (Difco, Augsburg, Germany) and an additional intraperito-
neal injection of 2 ! 109 heat-killed Bordetella pertussis (Institute of
Microbiology, Berlin, Germany) as previously described by Brack-
ertz et al. [16]. Finally, arthritis was induced on day 0 by injection of
100 Ìg mBSA in 50 Ìl saline into the left knee joint using a sterile
33-gauge microcannula. Control animals underwent the same proce-
dure but received only equivalent volumes of saline.
Experimental Groups
Animals were randomly assigned to two groups: a healthy control
group (n = 7) and a group with AIA (n = 7). To assess the severity of
AIA, joint swelling was determined daily until day 8 by measuring
the transverse diameter of the knee joint using a caliper in units of
0.1 mm. Intravital microscopy as well as tissue sampling were per-
formed on day 8 after AIA in both groups.
Surgical Preparation
Mice were anesthetized by inhalation of isoflurane 1.5% (Foren-
ce, Abbott, Wiesbaden, Germany) and a mixture of O2/N2O, using a
vaporizer (Dräger, Lübeck, Germany). Arterial and venous catheters
were implanted into the tail. The mean arterial blood pressure was
measured using the arterial catheter. Animals were kept on a heating
pad to stabilize body temperature. The left hind limb was placed on a
stage with the knee slightly flexed. Through a 1-cm incision distal to
the patellar tendon, the tendon was carefully mobilized, cut transver-
sally, and elevated to provide visual access to the intra-articular syno-
vial tissue as described elsewhere [15]. At the end of the experiment,
the animals were sacrificed with an intravenous injection of 10 mg
pentobarbital (Nembutal, Sanofi, Hannover, Germany). The knee
joints were then removed for immunohistochemistry. The experi-
ments were approved and performed according to the German legis-
lation for the protection of animals.
Intravital Fluorescence Microscopy
The microscopic setup has previously been described in detail
[17]. An intravital microscope (Zeiss, Oberkochen, Germany)
equipped with a 20-fold water immersion objective (total magnifica-
tion 432-fold: Zeiss, Jena, Germany) was used to visualize the syno-
vial microcirculation. Three regions of interest were selected, each
containing postcapillary venules (18–40 Ìm in diameter) or arterioles
(8–14 Ìm in diameter), as well as capillaries for the measurement of
functional capillary density (FCD). By means of a computer-con-
trolled platform which moves step by step driven by the computer,
identical vessel segments were reinvestigated with respect to the
parameters described above. For visualization of plasma, a variable
12-volt, 100-watt halogen light source and the Zeiss filter set 09 [band
pass (BP) 450–490, dichroic filter (FT) 510, long pass (LP) 520;
Zeiss] were used in conjunction with a bolus injection of fluorescein
isothiocyanate (FITC)-dextran (molecular mass 150 kD, 15 mg/kg
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Fig. 1. Course of changes in knee joint diam-
eter following arthritis induction (time point
indicated by the dotted line). Bars show the
mean B SEM of 7 animals per group. * p !
0.05 vs. control group.
mm
Days
0 1 2 3 4 5 6 7 8
0
5.0
6.0
AIA
Control
AIA induction
*
body weight intravenously; Sigma). Microscopic images were ac-
quired and recorded on videotape. Data analysis was performed off-
line using a computer-assisted analysis system (CAP-Image, Dr.
Zeintl, Heidelberg, Germany) [18].
Microcirculatory Parameters
The following microcirculatory parameters were assessed using
intravital microscopy: diameters of arterioles and venules, FCD (ves-
sels !10 Ìm in diameter), functional vessel density (FVD; vessels
110 Ìm in diameter) and the functional density of vessels exhibiting
angiogenic criteria (at least one of the following: convoluted vessel,
abrupt changes of diameter, vessels which are generated by sprouting
and progressively pruned and remodelled as described by Risau
[19]), defined as the length of red blood cell-perfused capillaries or
vessels within the observation area (expressed as cm/cm2).
Immunhistochemistry/Histological Score
Staining for vascular endothelial cells was performed on cryopre-
served tissue sections using the avidin-biotin immunoperoxidase
complex technique. Six-micrometer-thick sections, mounted on glass
slides, were deparaffinized with xylene. Endogenous peroxidase was
blocked by incubation with 2% hydrogen peroxide for 10 min. The
tissue sections were incubated for 1 h with the factor VIII-related
antigen/von Willebrand factor (vWF) monoclonal antibody (clone
F8/86, Dako, Glostrup, Denmark) at a 1 to 50 dilution. The revela-
tion of the staining was performed using the Vectastain Elite ABC
peroxidase mouse IgG kit (Vector, Burlingame, Calif., USA) and the
diaminobenzidine (Dako, Glostrup, Denmark) as chromogen. Perox-
idase-conjugated avidin was used at a dilution of 1:500. The sections
were finally counterstained with hematoxylin.
Microvessel density was determined according to the technique
of Weidner et al. [20] by using an ocular eyepiece screen and an
examination area of 0.25 mm2 at a total magnification of 200.
To analyze the extent and to evaluate the severity of the arthritis,
histological sections were performed using a standard scoring proto-
col introduced by Brackertz et al. [16].
Statistical Analysis
The data are expressed as mean B SEM. Statistical significance
was tested using a repeated measurements ANOVA on ranks (Fried-
man’s test) and Dunn’s follow-up testing. p values !0.05 were con-
sidered significant.
Results
Knee Joint Diameter
Figure 1 shows the time course of changes in knee joint
diameter in both groups over the observation time of 8
days after arthritis induction. In the control group there
was an increase in joint diameter on day 1, which was
most probably due to the injected volume. However, the
joint diameter returned to baseline values starting on day
2 in control mice. In contrast, significant swelling of the
knee joint was observed from day 2 until day 8 in mice
with AIA compared with the measurements in control
joints.
No significant change of the mean arterial blood pres-
sure occurred during the entire course of the experiment
in the two groups. The arthritic group demonstrated no
sign of a lack of care of their coat or any unusual behavior.
There was no significant loss of body weight in the AIA
group in comparison to the control group.
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Fig. 2. Capillaries, arterioles and venules in
the mouse synovial fat tissue visualized by
intravital fluorescence microscopy (plasma
stained with FITC-dextran). ! 432. A Ves-
sels of the control group. B High-density cap-
illary network and vessels with angiogenic
criteria of mice with AIA.
Microcirculatory Parameters
Typical FITC intravital microscopic images in a con-
trol mouse and in a mouse with AIA are shown in figure 2.
The tissue in the AIA mice presents a high-density capil-
lary network and arterioles and postcapillary venules with
angiogenic criteria. As shown in figure 3 there was no sig-
nificant difference in FCD between the control group
(337 B 9 cm/cm2; mean B SEM) and the AIA group
(359 B 13 cm/cm2). However AIA induction resulted in a
significant increase in the density of vessels 110 Ìm diam-
eter (135 B 10 cm/cm2) at day 8 compared to the control
group (61 B 5 cm/cm2). Furthermore, the density of
blood vessels with angiogenic criteria was significantly
enhanced in arthritic animals on day 8 after AIA induc-
tion (79 B 17 cm/cm2) in comparison to the control mice
(12 B 2 cm/cm2).
Immunohistochemistry/Histological Score
Immunohistochemistry revealed a strong expression of
vWF on the endothelium of synovial microvessels, as
shown in figure 4, mainly in the tissue sections of animals
with AIA, while it was only weak in the sections of control
animals. The results of the immunohistochemistry are
shown in figure 5. There was a significant increase in the
microvessel count in arthritic animals (297 B 25/mm–2)
in contrast to the control group (133 B 16/mm–2).
On day 8 after induction of arthritis, the histological
score revealed two or more synovial lining cells and peri-
vascular infiltration of leukocytes as well as hyperplasia of
synovium and pannus formation indicating that arthritis
has been induced in comparison to the control group as
shown in table 1.
Fig. 3. FCD (vessels !10 Ìm), FVD (vessels 110 Ìm) and density of
vessels with angiogenic criteria are shown. * p ! 0.05 vs. control
group (ctrl). Data are given as mean B SEM (n = 7).
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Discussion
One of the earliest features of rheumatoid synovitis is
the development of a new vascular network, which serves
to promote the delivery of cells and nutrients to the invad-
ing pannus [21]. Histological studies in patients with early
RA, who had clinical and histological evidence of knee
synovitis, have shown a significant increase in both vascu-
lar proliferation and the number of blood vessels per
square millimeter as compared with postmortem control
samples [22]. Several studies have suggested beneficial
effects of antiangiogenic therapy in RA. Antibodies to
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Fig. 4. Expression of vWF on synovial endo-
thelium. A Tissue sections of control ani-
mals. B Tissue sections of animals with
AIA.
Table 1. Histological score of all individual animals
Groups Histological score
0 1 2 3 4
Control (n = 7) 7 0 0 0 0
AIA (n = 7) 0 0 3 3 1
AIA: histological sections graded as 0 = normal knee joint; 1 =
normal synovium with occasional mononuclear cells; 2 = two and
more synovial lining cells and perivascular infiltrates of leukocytes;
3 = hyperplasia of synovium and dense infiltration; 4 = synovitis and
pannus formation and cartilage/subchondral bone erosions [16].
VEGF have been found to partially neutralize the prolif-
erative activity of endothelial cells in RA tissue explant
cultures [23]. In the rat model of collagen-induced arthri-
tis, angiogenesis inhibitors prevented the onset of colla-
gen-induced arthritis and suppressed established disease
[8, 10] in the presence of reduced serum concentrations of
VEGF [9]. Anti-Flt 1 treatment significantly reduced the
clinical signs of arthritis and revealed a 3-fold reduction
in a histological score of the degree of synovial hyperpla-
sia, inflammation and pannus formation in a mouse mod-
el of collagen-induced arthritis [24]. Treatment of human
RA with monoclonal antibody to TNF· significantly
reduced serum VEGF in a time- and dose-dependent
manner and correlated with alterations of disease parame-
ters, such as C-reactive protein (CRP) levels and swollen
joint score [25]. The effects of established antirheumatic
drugs, gold salts, D-penicillamine, methotrexate are
known to be partly mediated by inhibition of endothelial
cell proliferation [26, 27]. Monitoring response to treat-
ment rests on histological and clinical parameters such as
Fig. 5. Microvessel count. * p ! 0.05 vs. con-
trol group. Data are given as mean B SEM.
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joint swelling or systemic markers of joint inflammation,
such as CRP. Even effective control of inflammation does
not necessarily prevent deterioration of joint damage in
RA. Therefore, a better disease monitoring is essential if
better antiangiogenic strategies are to be developed.
The current study has shown for the first time in an
animal model of arthritis in vivo that there is an increase
of FVD at the site of inflammation. This was associated
with an increase of the density of vessels with angiogenic
criteria. Thus, there are significant changes occurring in
the synovial microcirculation of the knee joint during AIA
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which demonstrate that angiogenesis can be assessed
quantitatively using intravital microscopy.
AIA is an established animal model for the study of
human RA [16]. The main advantage of AIA in compari-
son to other established animal models is that arthritis is
induced in the knee joint which lends itself for microscop-
ic observations. The knee joint is the only joint which can
be accessed for intravital microscopy without inducing
major trauma [15]. In this study, arthritis was actually
induced in the knee, as shown by presence of swelling over
the entire observation period and the high histological
score on day 8 in all animals with AIA. Thus, the micro-
vascular changes in this study are due to AIA and are not
an artifact resulting from the surgical preparation [15].
The efficiency of exchange between the synovial capil-
laries and the joint cavity is dependent upon the number
of vessels and blood flow as well as endothelial permeabil-
ity. In the present work, angiogenesis, characterized by
FCD (vessels !10 Ìm in diameter), FVD (vessels 110 Ìm
in diameter) and the functional density of vessels exhib-
iting angiogenic criteria (convoluted vessels, abrupt
changes of diameter, vessels which are generated by
sprouting and progressively pruned and remodelled), in
the synovium was for the first time studied quantitatively
using intravital microscopy. The results of this study show
no significant difference in FCD between the control
group and the AIA group. However, the FVD was signifi-
cantly increased in animals with AIA. Furthermore, the
density of vessels exhibiting angiogenic criteria was signif-
icantly enhanced in arthritic animals. The term vessel
density indicates that only red blood cell-perfused vessels
are measured, this means blood vessels which are in-
volved in the oxygenation and nutrition of the tissue. Pre-
vious studies have relied on histology and could only
determine the anatomical vessel density in the synovium
without any knowledge of whether the vessels counted
were actually perfused or not [12, 13, 28].
There was no increase in the number of perfused capil-
laries (FCD) in arthritic animals in our study. This is likely
the result of the elevated joint pressure associated with
RA, because a large number of nonperfused capillaries
(!10 Ìm) were present in animals with AIA. The edema
formation which accompanies the influx of leukocytes
into the joint could result in a compression of the small
capillaries similar to that seen following ischemia-reperfu-
sion injury [29]. The compression of the capillaries leads to
a reduction of diameter and thus to a higher resistance to
flow, which can result in impaired nutritional blood flow.
Our results of an enhancement of FVD and of the den-
sity of blood vessels with angiogenic criteria are in agree-
ment with previous histological studies and are most like-
ly the result of angiogenesis which is known to occur in
chronic inflammation [11, 30]. Pannus formation in RA
involves proliferation, migration, and recruitment of in-
flammatory cells, which is associated with an increased
production of TNF·, IL-1, and nitric oxide; the latter
have been shown to exert both indirect and direct angiog-
enic activities [30]. Furthermore, it has previously been
demonstrated that the expression of E-selectin,VCAM-1,
and ·Vß3, which is detected in early RA synovial tissue
[31], is associated with angiogenesis [11, 32]. Thus, angio-
genesis is the major mechanism responsible for the signifi-
cant increase in FVD and density of vessels with angio-
genic criteria seen in animals with AIA.
In addition, there was a significant increase in the
microvessel count in arthritic animals. These results of
the immunohistochemical analysis confirm the observa-
tions made by means of intravital microscopy.
However, immunohistochemical methods for the de-
tection of vWF and the CD34 antigen on microvessels in
tumor tissue is hampered by costaining of a proportion of
the lymphatic vessels. Although neoplasms are assumed
not to elicit the formation of a new lymphatic drainage
system [33], the inclusion of preexisting lymphatic vessels
may lead to false-positive microvessel counts if their anti-
gens are also highlighted. By intravital microscopy after
intravenous injection of FITC-dextran lymphatic vessels
could not be detected. Lymphatics can only be stained by
local injection into the footpad of mice [34]. Therefore, it
is astonishing that in contrast to control animals we only
observed a nearly doubled number of the microvessel
count in arthritic mice whereas the density of angiogenic
vessels assessed by intravital microscopy was increased
more than 6 times compared to that of the control group.
In summary, in this study the in vivo changes of angio-
genesis in an animal model of arthritis have been quanti-
tatively assessed. This work describes for the first time a
quantitative intravital microscopic measure of vascular
density in arthritis disease, which seems to be more sensi-
tive in the registration of newly formed blood vessels than
microvessel count by vWF. Quantifying the rate of an-
giogenic enhancement may prove to be a useful technique
for evaluating drugs that influence angiogenesis.
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